Skip to main content
Tetra Bio-Pharma Inc. logo

Tetra Bio-Pharma Inc. — Investor Relations & Filings

Ticker · TBPMQ ISIN · CA88166Y1007 LEI · 5299000CYH3P8XC2UO53 TSX Manufacturing
Open in API
Filings indexed 720 across all filing types
Latest filing 2020-05-20 Capital/Financing Update
Country CA Canada
Listing TSX TBPMQ

About Tetra Bio-Pharma Inc.

https://tetrabiosciences.com/

Tetra Bio-Pharma is a biopharmaceutical company specializing in the discovery and development of cannabinoid-derived drugs and medicinal plant-based products. The company maintains an advanced pipeline encompassing biopharmaceuticals, natural health, and veterinary products. Clinical programs are focused on therapeutic areas such as inflammation, pain management (including alternatives to opioids), and ophthalmology. Tetra emphasizes rigorous clinical trials and scientific evidence, utilizing novel approaches, unique mechanisms of action, and high-quality delivery methods to address unmet patient needs.

Recent filings

Filing Released Lang Actions
Final short form prospectus – French.pdf
Capital/Financing Update Classification · 100% confidence The document is a 'prospectus simplifié préalable de base' (preliminary base shelf prospectus) for Tetra Bio-Pharma Inc., describing a securities offering of up to $50 million in various types of securities including common shares, warrants, units, debt securities, and subscription receipts. It includes detailed information about the offering, regulatory disclaimers, risk factors, and terms of the securities to be issued. This type of document is a formal offering document used to raise capital and inform investors about the terms and risks of the securities being offered. It is not an annual or quarterly report, earnings release, or management discussion. It is not a proxy, voting results, or governance document. It is not a merger or acquisition filing. It is not a regulatory filing or announcement of a report publication. It is a capital raising document describing financing activities and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a full prospectus, not a brief announcement or certification.
2020-05-20 English
Management information circular - French.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice and proxy solicitation circular for the Annual General Meeting (AGM) and Extraordinary General Meeting of shareholders of Tetra Bio-Pharma Inc. It includes the agenda for the meeting, instructions for shareholders on how to participate virtually, voting procedures, and proxy appointment details. It references the annual audited financial statements and auditor's report for the fiscal year ended November 30, 2019, but does not contain the financial statements themselves. The document is primarily intended to inform shareholders about the meeting and solicit their proxies, which fits the definition of Proxy Solicitation & Information Statement (PSI). It is not the Annual Report (10-K) or the Audit Report (AR) itself, nor is it a simple announcement of a report (RPA). The length and detail confirm it is a full proxy circular rather than a brief notice.
2020-05-20 English
Annual MD&A - French.pdf
Management Reports Classification · 95% confidence The document is titled 'RAPPORT DE GESTION' which translates to 'Management Report' and covers the twelve months ending November 30, 2019. It includes detailed sections such as company description, recent announcements, financing, clinical trial results, financial performance, and risk factors. It references financial statements prepared under IFRS and is dated March 25, 2020. The content is comprehensive and includes management's discussion of business activities, strategy, and financial results for the fiscal year. This matches the definition of a Management Report (MDA), which provides detailed explanation of financial results, business trends, and outlook. It is not an Annual Report (10-K) as it does not appear to be the full official yearly report, nor is it an Earnings Release or Interim Report. The length (15,000 characters) and detailed content confirm it is a substantive management report rather than a brief announcement or certification. Therefore, the correct classification is Management Reports (MDA).
2020-05-20 English
Audited annual financial statements – French.pdf
Annual Report Classification · 95% confidence The document contains an independent auditor's report on consolidated annual financial statements for the fiscal years ended November 30, 2019 and 2018, including the auditor's opinion, basis for opinion, and responsibilities of management and auditors. It also includes unaudited condensed interim consolidated financial statements for the three months ended February 29, 2020, with detailed financial data such as balance sheets, income statements, changes in equity, and cash flow statements. The presence of a full audit report and detailed financial statements for a full fiscal year indicates this is a comprehensive annual report. The document is lengthy (15,000 characters) and contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). Q1 2020
2020-05-20 English
Annual information form - French.pdf
Annual Report Classification · 95% confidence The document is titled 'Notice annuelle' for the fiscal year ended November 30, 2019, dated March 30, 2020, and is in French. It contains detailed sections typical of an annual report, including company structure, business development, risk factors, management profiles, and financial information presentation. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes forward-looking statements, risk factors, and detailed corporate information, all characteristic of an Annual Report (10-K equivalent). Therefore, the document is classified as an Annual Report (10-K). FY 2019
2020-05-20 English
Other.pdf
Regulatory Filings
2020-05-19 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.